Page 190 - Genentech News Today

Oregon lawmakers have put forth a plan to aid businesses and others seeking shares of billions available in federal money to encourage the domestic manufacturing of semiconductors.

AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that ten presentations will be delivered at the International Conference on Alzheimer’s & Parkinson’s Diseases (AD/PDTM 2023), taking place in Gothenburg, Sweden, and ...

Esther Aguilera and Cid Wilson will be present at the upcoming forum on April 4 to give their perspective on the battle for equity and inclusion.

20.03.2023 - Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced new long-term data for Evrysdi (risdiplam) in a broad range of people aged 2-25 years with spinal muscular atrophy (SMA) from the pivotal SUNFISH study. Data ... Seite 1

/PRNewswire/ -- Today, the American Diabetes Association® (ADA) and Genentech, a member of the Roche Group, announced a new partnership as part of the ADAs...

Data from pivotal SUNFISH study showed increases in motor function observed during the first year were maintained through the fourth year, while the overall rate of adverse events continued to decrease

BioNTech to receive exclusive worldwide license from OncoC4 to develop and commercialize its anti-CTLA-4 monoclonal antibody candidate, ONC-392BioNTech and...

Moderna's top executives delivered upbeat updates on the cancer vaccine it is developing with Merck & Co. at two investor conferences.

BlackDoctor.org (BDO), the leading online health & wellness destination for Black consumers, announces the highly anticipated list of distinguished honorees for the 8th Annual Top Blacks in Healthcare Awards Gala and Thought Leadership Event

Most neurologists in the U.S. are aware of the recent approval of Briumvi for relapsing forms of MS, according to a market research firm.